Analysing Clinical And Demographic Data From A Study On Oral Lichen Planus Patients
-
Published:2024-08-01
Issue:4
Volume:78
Page:303-310
-
ISSN:2255-890X
-
Container-title:Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
-
language:en
-
Short-container-title:
Author:
Kakar Jagriti1, Sokolovska Lība2, Dabuzinskiene Anita3, Murovska Modra2, Čēma Ingrīda1
Affiliation:
1. Department of Oral and Maxillofacial Surgery and Oral Medicine , Rīga Stradiņš University , 16 Dzirciema Str ., , Rīga , Latvia 2. Institute of Microbiology and Virology , Rīga Stradiņš University , 5 Rātsupītes Str ., Rīga , Latvia 3. Lithuanian University of Health Sciences , Institute of Anatomy , A. Mickevičiaus g. 9 , , Kaunas , Lithuania
Abstract
Abstract
Oral lichen planus (OLP) is a common mucocutaneous disorder affecting approximately 1–2% of the population, predominantly middle-aged women. This study aims to analyse the demographic and clinical characteristics of OLP patients treated at the Oral Medicine Centre of Institute of Stomatology, Rīga Stradiņš University. The cohort comprised adult patients diagnosed with OLP, who underwent structured clinical evaluations. The study identified significant patterns in age, gender distribution, clinical forms, and associated discomfort levels. Females constituted 75.76% of the cohort, with a mean age of 60 years. The reticular form of OLP was most prevalent, while the erosive form, associated with considerable discomfort, was more common in females. Treatment regimens varied, with Sol Kenalog 0.2% and Ointment Clobetasol 0.05% being the primary therapies. Sol Kenalog 0.2% was more effective in providing symptom relief and reducing relapse frequency. Chronic diseases and stress were prevalent among patients, complicating management and treatment outcomes. The study emphasises the need for personalised treatment strategies that consider the severity of the clinical form, patient comfort, and comorbid conditions. Further research is recommended to validate these findings and explore the underlying mechanisms of gender differences and the impact of comorbidities on OLP. The insights from this study aim to enhance clinical practices and improve patient outcomes.
Publisher
Walter de Gruyter GmbH
Reference26 articles.
1. Ashraf, S., Al-Maweri, S. A., Alaizari, N., Umair, A., Ariffin, Z., Alhajj, M. N., Kassim, S., Awan, K. H. (2020). The association between Epstein-Barr virus and oral lichen planus: A systematic review and meta-analysis. J. Oral Pathol. Med., 49 (10), 969–976. https://doi.org/10.1111/jop.13093. 2. Alrashdan, M. S., Cirillo, N., McCullough, M. J. (2021). Oral lichen planus: A literature review and update. J. Oral Pathol. Med., 50 (6), 549–556. https://doi.org/10.1111/jop.13137. 3. Carrozzo, M., Thorpe, R., Shirlaw, P. (2019). Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorithms, prognosis, management strategies. Periodontology, 80 (1), 105–125. https://doi.org/10.1111/prd.12260. 4. Chen, X., Zhang, N., Shi, Q. (2022). Genetic susceptibility to oral lichen planus. J. Dental Res., 101 (2), 158–166. https://doi.org/10.1177/00220345211063811. 5. Dave, A., Shariff, J., Philipone, E. (2021). Association between oral lichen planus and systemic conditions and medications: Case–control study. Oral Dis., 27, 515–524. https://doi.org/10.1111/odi.13572.
|
|